| 25 May 2026 |
Adipotide |
7.7 |
10mg |
12.4mg |
+23.8% |
96.60% |
Lab C |
| 25 May 2026 |
Cardiogen |
6.4 |
10mg |
10.1mg |
+0.6% |
96.85% |
Lab D |
| 25 May 2026 |
Thymosin Alpha-1 |
8.0 |
30mg |
29.8mg |
-0.5% |
97.90% |
Lab C |
| 24 May 2026 |
GHRP-2 Acetate |
6.6 |
20mg |
23.0mg |
+15.2% |
98.08% |
Lab C |
| 24 May 2026 |
Tirzepatide |
1.4 |
30mg |
(no batch claim) |
51.1mg |
+70.3% |
(no batch ID) |
| 24 May 2026 |
Tirzepatide |
4.1 |
30mg |
33.5mgpackage |
28.1mg |
-16.1% |
2025A56-12 |
| 24 May 2026 |
BPC157 5mg + TB500 5mg Blend |
6.2 |
2mg |
2.2mg |
+9.8% |
96.26% |
Lab D |
| 24 May 2026 |
Trenbolone Enanthate |
7.8 |
300mg/ml |
271.9mg/ml |
-9.4% |
97.08% |
Lab E |
| 24 May 2026 |
AICAR |
4.3 |
5mg |
5.1mg |
+1.6% |
98.88% |
Lab B |
| 24 May 2026 |
Retatrutide |
9.1 |
50mg |
57.4mgpackage |
53.8mg |
-6.3% |
2025B510-10 |
| 24 May 2026 |
HCG |
7.2 |
50mg |
56.5mg |
+13.1% |
97.79% |
Lab F |
| 24 May 2026 |
Pinealon |
5.1 |
2mg |
2.0mg |
-1.6% |
98.79% |
Lab G |
| 23 May 2026 |
Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) |
8.6 |
250mg/ml |
243.1mg/ml |
-2.8% |
96.44% |
Lab D |
| 23 May 2026 |
Cerebrolysin |
9.1 |
20mg |
23.6mg |
+18.0% |
96.98% |
Lab G |
| 23 May 2026 |
Estradiol Cypionate |
5.1 |
200mg/ml |
183.0mg/ml |
-8.5% |
98.82% |
Lab E |
| 23 May 2026 |
Ostarine (MK-2866) |
6.9 |
100mg |
113.5mg |
+13.5% |
95.80% |
Lab G |
| 23 May 2026 |
SR9009 |
4.0 |
10mg |
11.1mg |
+11.2% |
99.42% |
Lab E |
| 23 May 2026 |
PE 22-28 |
6.0 |
50mg |
61.0mg |
+22.0% |
97.85% |
Lab D |
| 23 May 2026 |
Semax |
6.8 |
50mg |
47.2mg |
-5.6% |
96.48% |
Lab D |
| 23 May 2026 |
Tirzepatide Raw |
4.3 |
500g |
600.8g |
+20.2% |
95.65% |
Lab F |
| 23 May 2026 |
Trenbolone Acetate |
7.7 |
200mg/ml |
201.2mg/ml |
+0.6% |
98.04% |
Lab E |
| 21 May 2026 |
Retatrutide |
8.1 |
15mg |
17.2mgpackage |
18.6mg |
+8.4% |
2025B53-11 |
| 21 May 2026 |
Boldenone Undecylenate (EQ) Raw |
7.2 |
1g |
1.2g |
+19.7% |
95.25% |
Lab G |
| 21 May 2026 |
P21 |
5.8 |
2mg |
1.9mg |
-3.3% |
95.12% |
Lab F |
| 21 May 2026 |
GHRP-2 Acetate |
6.3 |
20mg |
23.8mg |
+18.9% |
99.37% |
Lab D |
| 21 May 2026 |
Oxytocin Acetate |
6.6 |
10mg |
10.3mg |
+3.2% |
95.30% |
Lab G |
| 21 May 2026 |
T4 (Levothyroxine) |
6.7 |
10mg |
10.3mg |
+3.0% |
99.39% |
Lab E |
| 20 May 2026 |
Boldenone Undecylenate (EQ) Raw |
5.6 |
5g |
4.8g |
-4.4% |
95.01% |
Lab F |
| 19 May 2026 |
BPC157 10mg + TB500 10mg Blend |
5.3 |
2mg |
2.3mg |
+16.9% |
96.97% |
Lab A |
| 19 May 2026 |
Bronchogen |
8.9 |
20mg |
21.1mg |
+5.6% |
97.39% |
Lab D |
| 19 May 2026 |
Drostanolone Enanthate (Mast E) Raw |
6.6 |
1g |
1.2g |
+20.9% |
99.01% |
Lab A |
| 19 May 2026 |
Semax |
4.8 |
5mg |
4.3mg |
-13.1% |
98.77% |
Lab F |
| 17 May 2026 |
4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 |
5.8 |
100g |
124.4g |
+24.4% |
98.03% |
Lab E |
| 17 May 2026 |
BPC157 5mg + TB500 5mg Blend |
6.7 |
50mg |
53.5mg |
+7.0% |
95.71% |
Lab F |
| 17 May 2026 |
Hyaluronic acid |
5.9 |
10mg |
8.7mg |
-13.2% |
98.62% |
Lab C |
| 17 May 2026 |
KPV Oral |
4.0 |
10mg |
11.1mg |
+11.1% |
95.07% |
Lab G |
| 17 May 2026 |
Ostarine (MK-2866) |
6.3 |
50mg |
46.1mg |
-7.8% |
99.49% |
Lab F |
| 29 Jan 2026 |
ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 |
6.1 |
5g |
6.1g |
+22.2% |
96.30% |
Lab F |
| 29 Jan 2026 |
Superdrol |
4.2 |
10mg |
10.8mg |
+8.1% |
99.89% |
Lab F |
| 26 Jan 2026 |
Retatrutide |
8.5 |
15mg |
17.2mgpackage |
15.9mg |
-7.3% |
2025B53-11 |
| 26 Jan 2026 |
Tirzepatide |
7.3 |
30mg |
(no batch claim) |
35.3mg |
+17.7% |
2025A56-10 |
| 26 Jan 2026 |
Cardiogen |
6.9 |
10mg |
10.1mg |
+0.8% |
95.66% |
Lab B |
| 26 Jan 2026 |
EPO |
5.6 |
30mg |
25.6mg |
-14.6% |
98.42% |
Lab G |
| 26 Jan 2026 |
Orforglipron |
4.5 |
25mg |
29.5mg |
+17.9% |
98.93% |
Lab D |
| 26 Jan 2026 |
Super Shred |
9.0 |
100mg/ml |
95.4mg/ml |
-4.6% |
99.37% |
Lab F |
| 19 Jan 2026 |
Retatrutide |
6.8 |
50mg |
57.4mgpackage |
47.1mg |
-18.0% |
2025B510-10 |
| 19 Jan 2026 |
FOXO4 |
6.5 |
2mg |
1.8mg |
-8.8% |
99.38% |
Lab F |
| 7 Jan 2026 |
Hyaluronic acid |
7.1 |
30mg |
25.6mg |
-14.5% |
96.92% |
Lab B |
| 7 Jan 2026 |
P21 |
5.2 |
30mg |
26.8mg |
-10.7% |
99.75% |
Lab D |
| 7 Jan 2026 |
Thymalin |
6.0 |
30mg |
33.3mg |
+11.0% |
98.40% |
Lab C |
| 7 Jan 2026 |
YK-11 Raw |
6.7 |
10g |
9.9g |
-1.2% |
99.55% |
Lab E |
| 29 Dec 2025 |
Trenbolone Enanthate |
8.8 |
100mg/ml |
110.4mg/ml |
+10.4% |
96.52% |
Lab B |
| 29 Dec 2025 |
YK-11 Raw |
5.6 |
100g |
112.8g |
+12.8% |
97.63% |
Lab C |
| 12 Dec 2025 |
4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 |
5.9 |
10g |
12.1g |
+21.5% |
97.02% |
Lab C |
| 5 Dec 2025 |
EPO |
6.0 |
30mg |
28.3mg |
-5.6% |
97.98% |
Lab G |
| 23 Nov 2025 |
Orforglipron |
5.0 |
50mg |
50.4mg |
+0.7% |
97.57% |
Lab F |
| 17 Nov 2025 |
Estradiol Cypionate |
6.2 |
100mg/ml |
93.9mg/ml |
-6.1% |
95.52% |
Lab G |
| 5 Nov 2025 |
FOXO4 |
6.3 |
50mg |
50.7mg |
+1.3% |
97.90% |
Lab D |
| 4 Nov 2025 |
AICAR |
4.2 |
10mg |
11.5mg |
+14.6% |
98.26% |
Lab F |
| 4 Nov 2025 |
Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) |
6.0 |
200mg/ml |
211.1mg/ml |
+5.6% |
96.58% |
Lab A |
| 4 Nov 2025 |
Proviron (Mesterolone) |
7.6 |
50mg |
51.5mg |
+3.0% |
95.02% |
Lab B |
| 17 Oct 2025 |
Cartalax |
4.0 |
5mg |
4.9mg |
-1.2% |
99.29% |
Lab C |
| 17 Oct 2025 |
Proviron (Mesterolone) |
7.1 |
50mg |
43.1mg |
-13.7% |
95.54% |
Lab G |
| 9 Oct 2025 |
Oxytocin Acetate |
6.3 |
30mg |
35.7mg |
+19.1% |
97.24% |
Lab A |
| 9 Oct 2025 |
T4 (Levothyroxine) |
6.7 |
25mg |
27.1mg |
+8.5% |
98.58% |
Lab B |
| 3 Oct 2025 |
Anastrozole (Arimidex) Raw |
4.0 |
10g |
10.7g |
+6.8% |
96.36% |
Lab B |